Saturday, September 10, 2016

7:00–8:00 am Registration and Breakfast
8:00-8:45 Overview: Addressing Pain/Screening and Recognizing Addiction
Opioid Dependence and Its Treatment
The Drug Addiction Treatment Act of 2000

Elinore McCance-Katz, MD, PhD
8:45-9:30 Good Prescribing Practices
Using the New & Improved Rhode Island (RI) Prescription Monitoring Program
RI Controlled Substance Regulations for Prescribers
James V. McDonald, MD, MPH
Medication Assisted Treatment and Evidence-Based Counseling for Opioid Use Disorders
Kevin Baill, MD
10:30-10:40 Break
10:40-11:40 General Opioid Pharmacology & Pharmacology of Buprenorphine/Safety and Efficacy of Buprenorphine
Peter D. Friedmann, MD, MPH
11:40-12:20 pm Patient Assessment and Selection
Laura Levine, MD
12:20-12:50 Clinical Use of Buprenorphine: Induction, Stabilization, Maintenance, & Withdrawal
Elinore McCance-Katz, MD, PhD
12:50-1:20 Small Group/Case Discussions
Please go to your assigned breakout section

Case I: Addicted School Teacher: Treatment Options
Case II: Lawyer Using Daily: Clinical Management
1:20-2:10 Lunch & Performance by Four Legs to Stand On
2:10-2:55 Clinical Management
Elinore McCance-Katz, MD, PhD
2:55-3:25 Confidentiality, Medical Records, Office Policies & Procedures
Kevin Baill, MD
3:25-4:10 Opioid Addiction Treatment for Special Populations
Tracey Cohen, MD
4:10-4:20 Break
4:20-4:50 Small Group/Case Discussions
Please go to your assigned breakout section

Case III: Overuse of Pain Medication: Treatment Considerations
Case IV: College Student With Opioid Addiction: Clinical Management
4:50-5:20 Opioid Overdose Prevention and Appropriate Clinical Use of Naloxone
Traci C. Green, PhD, MSc
5:20-5:30 pm Completion of DEA Waiver and Question and Answer Session
Elinore McCance-Katz, MD, PhD